Author:
Hale Geoff,Rebello Peppy,Al Bakir Ibrahim,Bolam Emma,Wiczling Pawel,Jusko William J.,Vandemeulebroucke Evy,Keymeulen Bart,Mathieu Chantal,Ziegler Annette-G,Chatenoud Lucienne,Waldmann Herman
Subject
Pharmacology (medical),Pharmacology
Reference21 articles.
1. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties;Wauwe;J Immunol,1980
2. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients;Abramowicz;Transplantation,1989
3. Side effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review;Sgro;Toxicology,1995
4. A non-activating “humanized” anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo;Alegre;Transplantation,1994
5. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection;Woodle;Transplantation,1999
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献